Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L C Pagliaro

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
Phase I study of suramin combined with doxorubicin in the treatment of androgen-independent prostate cancerS M Tu, L C Pagliaro, M E Banks, et al.
European Journal of Cancer (Oxford, England : 1990)|July 2, 2013
Outcomes of patients with metastatic clear-cell renal cell carcinoma treated with pazopanib after disease progression with other targeted therapiesM R Matrana, C Duran, A Shetty, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|June 1, 1995
Recombinant human retinoblastoma protein inhibits cancer cell growthL C Pagliaro, D Antelman, D E Johnson, et al.
Prostate Cancer and Prostatic Diseases|July 15, 2015
Integrating chemohormonal therapy and surgery in known or suspected lymph node metastatic prostate cancerA J Zurita, L L Pisters, X Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 2010
Outcome of patients with metastatic renal cell carcinoma treated with targeted therapy without cytoreductive nephrectomyS L Richey, S H Culp, E Jonasch, et al.
Lancet (London, England)|February 24, 2001
Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trialS M Tu, R E Millikan, B Mengistu, et al.
British Journal of Cancer|June 27, 2002
Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumoursK Fizazi, D M Prow, K-A Do, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
Phase I study of suramin combined with doxorubicin in the treatment of androgen-independent prostate cancerS M Tu, L C Pagliaro, M E Banks, et al.
European Journal of Cancer (Oxford, England : 1990)|July 2, 2013
Outcomes of patients with metastatic clear-cell renal cell carcinoma treated with pazopanib after disease progression with other targeted therapiesM R Matrana, C Duran, A Shetty, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|June 1, 1995
Recombinant human retinoblastoma protein inhibits cancer cell growthL C Pagliaro, D Antelman, D E Johnson, et al.
Prostate Cancer and Prostatic Diseases|July 15, 2015
Integrating chemohormonal therapy and surgery in known or suspected lymph node metastatic prostate cancerA J Zurita, L L Pisters, X Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 2010
Outcome of patients with metastatic renal cell carcinoma treated with targeted therapy without cytoreductive nephrectomyS L Richey, S H Culp, E Jonasch, et al.
Lancet (London, England)|February 24, 2001
Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trialS M Tu, R E Millikan, B Mengistu, et al.
British Journal of Cancer|June 27, 2002
Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumoursK Fizazi, D M Prow, K-A Do, et al.
Pageof 2